Glaucoma is a leading cause of irreversible visual loss. This potentially blinding disease is a
progressive optic neuropathy associated with elevated intraocular pressure (IOP). Initial …

Fixed combinations of topical glaucoma medications : Current Opinion in Ophthalmology Fixed
combinations of topical glaucoma medications : Current Opinion in Ophthalmology Log in or …

ABSTRACT Introduction Fixed dose combinations (FCs) represent a potentially valuable
treatment strategy in glaucoma management. Fixed combinations not only improve …

The first-line option for lowering intraocular pressure (IOP) is a single hypotensive agent, but
patients frequently require additional IOP-lowering agents to reach their target pressures …

Fixed combinations of medications that lower intraocular pressure (IOP) are increasingly
used in the treatment of glaucoma and ocular hypertension and offer several potential …

Prescribing medical therapy for the treatment of glaucoma can be a complex process since
many parameters should be taken into consideration regarding its achievements and limits …

Introduction: Several large, randomized, prospective clinical trials have demonstrated that
medical therapy to reduce intraocular pressure (IOP) delays the onset and decreases …

Ocular hypotensive agents are the only approved pharmacotherapy for glaucoma. Despite
significant advances during the past two decades, a large proportion of glaucoma patients …

Glaucomatous optic atrophy is the second most common cause of blindness worldwide, and
lowering intraocular pressure (IOP) is the only proven method to slow or stop the …

Prostaglandin analogs are currently the first-line agents in the medical treatment of
glaucoma. Frequently, more than one drug is needed to control intraocular pressure. Beta …